Viewing Study NCT03917550


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2025-12-24 @ 4:59 PM
Study NCT ID: NCT03917550
Status: UNKNOWN
Last Update Posted: 2019-04-17
First Post: 2019-04-14
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression
Sponsor: West University of Timisoara
Organization:

Study Overview

Official Title: RECOVERY: An Internet-delivered Transdiagnostic Cognitive Behavior Therapy in Romania
Status: UNKNOWN
Status Verified Date: 2019-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RECOVERY
Brief Summary: To investigate the efficacy and acceptability of a guided internet delivered transdiagnostic intervention, targeting mild to moderate clinical symptoms of anxiety and depression and emphasizing the changes taking place at the level of the structures of the self.
Detailed Description: The effectiveness of a Transdiagnostic Cognitive-Behavioral Treatment will be compared with an improved version of it, in which new intervention techniques were added, pointing out the importance of improving some self-concept dimensions in reducing symptoms of anxiety and depression. In order to prove this, the study design will include two active intervention groups; a standard transdiagnostic intervention protocol will be delivered to one group and an improved version of the same transdiagnostic protocol will be delivered to the other group. The new added techniques targets some self-concepts, namely self-compassion, unconditional self-acceptance and self-esteem. The main goal of the study is to concurrently test effectiveness of these two transdiagnostic approaches in reducing symptoms of anxiety and depression and improving the above-mentioned self-concepts. This non-inferiority trial has the power to detect an effect size larger than Cohen's d = .40 (including 20% attrition at post-test and 6 month follow-up)

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: